AllianceBernstein
CANO

AllianceBernstein’s Cano Health, Inc. CANO Stock Holding History

AllianceBernstein’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,893
Closed -$98.7K – 3247
2023
Q3 		$98.7K Sell
3,893
-277
-7% -$22.8K ﹤0.01% 3071
2023
Q2 		$580K Buy
4,170
+489
+13% +$62.8K ﹤0.01% 2555
2023
Q1 		$335K Buy
3,681
+751
+26% +$102K ﹤0.01% 2732
2022
Q4 		$401K Buy
2,930
+837
+40% +$283K ﹤0.01% 2745
2022
Q3 		$1.81M Buy
2,093
+499
+31% +$313K ﹤0.01% 1953
2022
Q2 		$698K Buy
1,594
+594
+59% +$310K ﹤0.01% 2525
2022
Q1 		$635K Sell
1,000
-250
-20% -$158K ﹤0.01% 2581
2021
Q4 		$1.11M Buy
+1,250
New +$1.31M ﹤0.01% 2423

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein's CANO Position: Q4 2023 in Review

AllianceBernstein sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 3,893 shares — an estimated $98.7K sold.

AllianceBernstein first reported a position in CANO in Q4 2021 and held it in 8 quarters. The position peaked at $1.81M in Q3 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • AllianceBernstein reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • AllianceBernstein sold 3,893 Cano Health, Inc. shares in Q4 2023, an estimated $98.7K.
  • AllianceBernstein first reported a position in Cano Health, Inc. in Q4 2021 and held it in 8 quarters.
  • AllianceBernstein's Cano Health, Inc. position peaked at $1.81M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on AllianceBernstein's 13F filing for Q4 2023, filed 14 Feb 2024.